[
    [
        {
            "time": "2018-10-10",
            "original_text": "Abbott Laboratories Expected to Report Q3 Sales of $7.6 Billion",
            "features": {
                "keywords": [
                    "Abbott Laboratories",
                    "Q3 Sales",
                    "Expected",
                    "$7.6 Billion"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbott Laboratories Expected to Report Q3 Sales of $7.6 Billion",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-10-10",
            "original_text": "JNJ’s Consumer Business Expected to Be Driven by Innovation",
            "features": {
                "keywords": [
                    "JNJ",
                    "Consumer Business",
                    "Innovation",
                    "Expected"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "JNJ’s Consumer Business Expected to Be Driven by Innovation",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-12",
            "original_text": "Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018",
            "features": {
                "keywords": [
                    "Abbott Laboratories",
                    "Ex-Dividend Date",
                    "Scheduled",
                    "October 12, 2018"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-10-10",
            "original_text": "Analysts Raise Target Prices on ABT ahead of Q3 Earnings",
            "features": {
                "keywords": [
                    "Analysts",
                    "Raise",
                    "Target Prices",
                    "ABT",
                    "Q3 Earnings"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Analysts Raise Target Prices on ABT ahead of Q3 Earnings",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]